Portal de Periódicos da CAPES

Giant cell tumor of bone with pulmonary metastases

2003; Alan R. Liss, Inc.; Volume: 41; Issue: 5 Linguagem: Inglês

10.1002/mpo.10258

1096-911X

Yasuhiro Okamoto, Susan Mathew, Najat C. Daw, Michael D. Neel, M. Beth McCarville, Jeffrey S. Dome, D. Ashley Hill,

Sarcoma Diagnosis and Treatment

Medical and Pediatric OncologyVolume 41, Issue 5 p. 454-459 Proceedings of the Tumor Board Giant cell tumor of bone with pulmonary metastases Yasuhiro Okamoto MD, Yasuhiro Okamoto MD Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorSusan Mathew PhD, Susan Mathew PhD Department of Pathology, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorNajat C. Daw MD, Najat C. Daw MD Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee Department of Pediatrics, The University of Tennessee College of Medicine, Memphis, TennesseeSearch for more papers by this authorMichael D. Neel MD, Michael D. Neel MD Department of Surgery, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorM. Beth McCarville MD, M. Beth McCarville MD Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorJeffrey S. Dome MD, Jeffrey S. Dome MD Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorD. Ashley Hill MD, Corresponding Author D. Ashley Hill MD [email protected] Department of Pathology, St. Jude Children's Research Hospital, Memphis, TennesseeLauren V. Ackerman Division of Surgical Pathology, Washington University Medical Center, 660 S. Euclid Ave., St. Louis, MO 68110.Search for more papers by this author Yasuhiro Okamoto MD, Yasuhiro Okamoto MD Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorSusan Mathew PhD, Susan Mathew PhD Department of Pathology, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorNajat C. Daw MD, Najat C. Daw MD Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee Department of Pediatrics, The University of Tennessee College of Medicine, Memphis, TennesseeSearch for more papers by this authorMichael D. Neel MD, Michael D. Neel MD Department of Surgery, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorM. Beth McCarville MD, M. Beth McCarville MD Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorJeffrey S. Dome MD, Jeffrey S. Dome MD Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TennesseeSearch for more papers by this authorD. Ashley Hill MD, Corresponding Author D. Ashley Hill MD [email protected] Department of Pathology, St. Jude Children's Research Hospital, Memphis, TennesseeLauren V. Ackerman Division of Surgical Pathology, Washington University Medical Center, 660 S. Euclid Ave., St. Louis, MO 68110.Search for more papers by this author First published: 22 September 2003 https://doi.org/10.1002/mpo.10258Citations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Dorfman HD. Giant-cell lesions. In: HD Dorfman, editor. Bone tumors. St. Louis: Mosby, Inc.; 1998. p 559–606. 2 Teot LA, O'Keefe RJ, Rosier RN, et al. Extraosseous primary and recurrent giant cell tumors: Transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation. Hum Pathol 1996; 27: 625–632. 3 Schwartz HS, Butler MG, Jenkins RB, et al. Telomeric associations and consistent growth factor overexpression detected in giant cell tumor of bone. Cancer Genet Cytogenet 1991; 56: 263–276. 4 Bridge JA, Neff JR, Mouron BJ. Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet 1992; 58: 2–13. 5 Zheng MH, Siu P, Papadimitriou JM, et al. Telomeric fusion is a major cytogenetic aberration of giant cell tumors of bone. Pathology 1999; 31: 373–378. 6 Mandahl N, Heim S, Kristoffersson U, et al. Telomeric association in a malignant fibrous histiocytoma. Hum Genet 1985; 71: 321–324. 7 Mandahl N, Heim S, Arheden K, et al. Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet Cytogenet 1988; 30: 23–33. 8 Dewald GW, Dahl RJ, Spurbeck JL, et al. Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin Proc 1987; 62: 558–567. 9 Kovacs G, Muller-Brechlin R, Szucs S. Telomeric association in two human renal tumors. Cancer Genet Cytogenet 1987; 28: 363–366. 10 Harrison KJ, Neumann E, Kalousek DK, et al. Astrocytoma with a unique telomere association. Cancer Genet Cytogenet 1994; 76: 33–35. 11 Hemann MT, Strong MA, Hao L, et al. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107: 67–77. 12 Griffith JD, Corneau L, Rosenfield S, et al. Mammalian telomeres end in a large duplex loop. Cell 1999; 97: 503–514. 13 Karlseder J, Broccoli D, Dai Y, et al. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283: 1321–1325. 14 Schwartz HS, Dahir GA, Butler MG. Telomere reduction in giant cell tumor of bone and with aging. Cancer Genet Cytogenet 1993; 71: 132–138. 15 Schwartz HS, Juliao SF, Sciadini MF, et al. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 1995; 75: 1094–1099. 16 Lansdorp PM, Verwoerd NP, van de Rijke FM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996; 5: 685–691. 17 Mirra JM, Ulich T, Magidson J, et al. A case of probable benign pulmonary "metastases" or implants arising from a giant cell tumor of bone. Clin Orthop 1982; 162: 245–254. 18 Bertoni F, Present D, Sudanese A, et al. Giant-cell tumor of bone with pulmonary metastases. Six case reports and a review of the literature. Clin Orthop 1988; 237: 275–285. 19 Maloney WJ, Vaughan LM, Jones HH, et al. Benign metastasizing giant-cell tumor of bone. Report of three cases and review of the literature. Clin Orthop 1989; 243: 208–215. 20 Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: A clinicopathologic study of prognostic factors. Pathol Int 1998; 48: 723–729. 21 Katz E, Nyska M, Okon E, et al. Growth rate analysis of lung metastases from histologically benign giant cell tumor of bone. Cancer 1987; 59: 1831–1836. 22 Siebenrock KA, Unni KK, Rock MG. Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br 1998; 80: 43–47. 23 Tubbs WS, Brown LR, Beabout JW, et al. Benign giant-cell tumor of bone with pulmonary metastases: Clinical findings and radiologic appearance of metastases in 13 cases. AJR Am J Roentgenol 1992; 158: 331–334. 24 Jaffe HL, Lichtenstein L, Portis RB. Giant cell tumor of bone: Its pathologic appearance, grading, supposed variants, and treatment. Arch Pathol 1940; 30: 993–1031. 25 Kay RM, Eckardt JJ, Seeger LL, et al. Pulmonary metastasis of benign giant cell tumor of bone. Six histologically confirmed cases, including one of spontaneous regression. Clin Orthop 1994; 302: 219–230. Citing Literature Volume41, Issue5November 2003Pages 454-459 ReferencesRelatedInformation